Literature DB >> 23019148

Unraveling the ubiquitin-regulated signaling networks by mass spectrometry-based proteomics.

Teck Yew Low1, Roberto Magliozzi, Daniele Guardavaccaro, Albert J R Heck.   

Abstract

Ubiquitin (Ub) is a small protein modifier that is covalently attached to the ε-amino group of lysine residues of protein substrates, generally targeting them for degradation. Due to the emergence of specific anti-diglycine (-GG) antibodies and the improvement in MS, it is now possible to identify more than 10 000 ubiquitylated sites in a single proteomics study. Besides cataloging ubiquitylated sites, it is equally important to unravel the biological relationship between ubiquitylated substrates and the ubiquitin conjugation machinery. Relevant to this, we discuss the role of affinity purification-MS (AP-MS), in characterizing E3 ligase-substrate complexes. Recently, such strategies have also been adapted to screen for binding partners of both deubiquitylating enzymes (DUBs) and ubiquitin-binding domains (UBDs). The complexity of the "ubiquitome" is further expanded by the fact that Ub itself can be ubiquitylated at any of its seven lysine residues forming polyubiquitin (polyUb), thus diversifying its lengths and topologies to suit a variety of molecular recognition processes. Therefore, applying MS to study polyUb linkages is also becoming an emerging and important area. Finally, we discuss the future of MS-based proteomics in answering important questions with respect to ubiquitylation.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23019148     DOI: 10.1002/pmic.201200244

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  9 in total

1.  ETD Outperforms CID and HCD in the Analysis of the Ubiquitylated Proteome.

Authors:  Tanya R Porras-Yakushi; Michael J Sweredoski; Sonja Hess
Journal:  J Am Soc Mass Spectrom       Date:  2015-05-21       Impact factor: 3.109

Review 2.  Quantifying ubiquitin signaling.

Authors:  Alban Ordureau; Christian Münch; J Wade Harper
Journal:  Mol Cell       Date:  2015-05-21       Impact factor: 17.970

3.  Enhanced detection of ubiquitin isopeptides using reductive methylation.

Authors:  Navin Chicooree; Yvonne Connolly; Chong-Teik Tan; Angeliki Malliri; Yaoyong Li; Duncan L Smith; John R Griffiths
Journal:  J Am Soc Mass Spectrom       Date:  2013-01-30       Impact factor: 3.109

Review 4.  SUMO proteomics to decipher the SUMO-modified proteome regulated by various diseases.

Authors:  Wei Yang; Wulf Paschen
Journal:  Proteomics       Date:  2014-10-28       Impact factor: 3.984

5.  Preparing to read the ubiquitin code: a middle-out strategy for characterization of all lysine-linked diubiquitins.

Authors:  Amanda E Lee; Carlos A Castañeda; Yan Wang; David Fushman; Catherine Fenselau
Journal:  J Mass Spectrom       Date:  2014-12       Impact factor: 1.982

6.  Decoding the ubiquitin-mediated pathway of arthropod disease vectors.

Authors:  Anthony Choy; Maiara S Severo; Ruobai Sun; Thomas Girke; Joseph J Gillespie; Joao H F Pedra
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

7.  Ubiquitination-mediated molecular pathway alterations in human lung squamous cell carcinomas identified by quantitative ubiquitinomics.

Authors:  Xianquan Zhan; Miaolong Lu; Lamei Yang; Jingru Yang; Xiaohan Zhan; Shu Zheng; Yuna Guo; Biao Li; Siqi Wen; Jiajia Li; Na Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-15       Impact factor: 6.055

8.  A genome-scale CRISPR-Cas9 screening method for protein stability reveals novel regulators of Cdc25A.

Authors:  Yuanzhong Wu; Liwen Zhou; Xin Wang; Jinping Lu; Ruhua Zhang; Xiaoting Liang; Li Wang; Wuguo Deng; Yi-Xin Zeng; Haojie Huang; Tiebang Kang
Journal:  Cell Discov       Date:  2016-05-24       Impact factor: 10.849

9.  Label-free quantitative identification of abnormally ubiquitinated proteins as useful biomarkers for human lung squamous cell carcinomas.

Authors:  Miaolong Lu; Wei Chen; Wei Zhuang; Xianquan Zhan
Journal:  EPMA J       Date:  2020-01-04       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.